These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25216904)

  • 21. The role of esophageal pH-impedance testing in clinical practice.
    Hobbs P; Gyawali CP
    Curr Opin Gastroenterol; 2018 Jul; 34(4):249-257. PubMed ID: 29846260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Catheter-free pH-metry using the Bravo capsule versus standard pH-metry in patients with non-erosive reflux disease (NERD)].
    Mönkemüller K; Neumann H; Fry LC; Kolfenbach S; Malfertheiner P
    Z Gastroenterol; 2009 Apr; 47(4):351-6. PubMed ID: 19358061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Laboratory based investigations for diagnosing gastroesophageal reflux disease.
    Dolder M; Tutuian R
    Best Pract Res Clin Gastroenterol; 2010 Dec; 24(6):787-98. PubMed ID: 21126694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telemetry capsule for ambulatory pH monitoring: is it time for a change?
    Katz PO; Matheus T
    Am J Gastroenterol; 2008 Dec; 103(12):2986-7. PubMed ID: 18786108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impedance-pH monitoring: new standard for measuring gastro-oesophageal reflux.
    Bredenoord AJ
    Neurogastroenterol Motil; 2008 May; 20(5):434-9. PubMed ID: 18416700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reflux monitoring: pH-metry, Bilitec and oesophageal impedance measurements.
    Pohl D; Tutuian R
    Best Pract Res Clin Gastroenterol; 2009; 23(3):299-311. PubMed ID: 19505660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is impedance pH monitoring superior to the conventional 24-h pH meter in the evaluation of patients with laryngorespiratory symptoms suspected to be due to gastroesophageal reflux disease?
    Ang D; Ang TL; Teo EK; Hsu PP; Tee A; Poh CH; Tan J; Ong J; Fock KM
    J Dig Dis; 2011 Oct; 12(5):341-8. PubMed ID: 21955426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review article: oesophageal pH monitoring--technologies, interpretation and correlation with clinical outcomes.
    Kahrilas PJ; Pandolfino JE
    Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():2-9. PubMed ID: 16303031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Twenty-four hour ambulatory simultaneous impedance and pH monitoring: a multicenter report of normal values from 60 healthy volunteers.
    Shay S; Tutuian R; Sifrim D; Vela M; Wise J; Balaji N; Zhang X; Adhami T; Murray J; Peters J; Castell D
    Am J Gastroenterol; 2004 Jun; 99(6):1037-43. PubMed ID: 15180722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
    Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
    Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy, diagnostic utility and tolerance of intraesophageal pH ambulatory determination with wireless pH-testing monitoring system].
    Carmona-Sánchez R; Solana-Sentíes S
    Rev Gastroenterol Mex; 2004; 69(2):69-75. PubMed ID: 15757154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multichannel intraluminal impedance and pH monitoring in gastroesophageal reflux disease.
    Vela MF
    Expert Rev Gastroenterol Hepatol; 2008 Oct; 2(5):665-72. PubMed ID: 19072344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of measurement of esophageal acid exposure close to the gastroesophageal junction on diagnostic accuracy and event-symptom correlation: a prospective study using wireless dual pH monitoring.
    Bansal A; Wani S; Rastogi A; Rastogi K; Goyal A; Hall S; Singh V; Higbee A; Sharma P
    Am J Gastroenterol; 2009 Dec; 104(12):2918-25. PubMed ID: 19755975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastroesophageal reflux and atypical symptoms: the role of impedance-pH monitoring.
    Fornari F; Sifrim D
    Digestion; 2007; 76(3-4):221-2. PubMed ID: 18174684
    [No Abstract]   [Full Text] [Related]  

  • 35. Swallow evaluation during multichannel intraluminal impedance and pH: an alternate method to assess esophageal transit.
    Hila A; Chowdhury N; Hajar N; Castell DO
    J Clin Gastroenterol; 2011; 45(10):862-6. PubMed ID: 21857530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimal thresholds and discriminatory power of 48-h wireless esophageal pH monitoring in the diagnosisof GERD.
    Wenner J; Johansson J; Johnsson F; Oberg S
    Am J Gastroenterol; 2007 Sep; 102(9):1862-9. PubMed ID: 17509034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [pH-impedancemetry: clinical implications].
    Bertolini D; Roman S; Dumonceau JM
    Rev Med Suisse; 2008 Sep; 4(169):1873-4, 1876-8. PubMed ID: 18831408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review article: modern technology in the diagnosis of gastro-oesophageal reflux disease--Bilitec, intraluminal impedance and Bravo capsule pH monitoring.
    Hirano I
    Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():12-24. PubMed ID: 16483266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ambulatory esophageal pH monitoring: new directions.
    Dickman R; Fass R
    Dig Dis; 2006; 24(3-4):313-8. PubMed ID: 16849859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Technology insight: The role of impedance testing for esophageal disorders.
    Sifrim D; Blondeau K
    Nat Clin Pract Gastroenterol Hepatol; 2006 Apr; 3(4):210-9. PubMed ID: 16582963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.